Asela Weerawardhana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Asela Weerawardhana has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Jong-Soo Lee
College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungnam National University, Yuseong-gu, Daejeon 34134, Republic of Korea
17 shared publications Nuwan Gamage
College of Veterinary Medicine, Chungnam National University, DaeJeon, Republic of Korea
9 shared publicationsKiramage Chathuranga
Laboratory of Microbiology, College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea
8 shared publicationsAshan Subasinghe
College of Veterinary Medicine, Chungnam National University, DaeJeon, Republic of Korea
6 shared publicationsD. K. Haluwana
College of Veterinary Medicine, Chungnam National University, DaeJeon, Republic of Korea
5 shared publicationsJi-Won Cha
College of Veterinary Medicine, Chungnam National University, DaeJeon, Republic of Korea
5 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Springer Nature in Veterinary Research
- Vol. 57 (1) , 196
African swine fever virus histone-like protein A104R subverts host antiviral defenses by suppressing the nuclear translocation of IRF3 and STAT1
A104R of African swine fever virus (ASFV), putative histone-like protein, is known to be involved in essential processes such as viral DNA replication, repair, and transcription. Although it has been revealed that the deletion of A104R affects ASFV pathogenicity for live attenuated vaccine development, the molecular mechanism underlying those effects remains unclear. Here, we report a novel molecular mechanism of A104R that suppresses karyopherin-α (KPNA) mediated antiviral responses. A104R competitively bound to the major nuclear localization signal (NLS) region on KPNA3 and KPNA4, thereby disrupting their interaction with interferon regulatory factor 3 (IRF3). A104R also bound to the unique C terminal nonclassical NLS region of KPNA6 and competitively inhibited the interaction between KPNA6 and phosphorylated signal transducer and activator of transcription 1 (STAT1). Therefore, A104R inhibited the nuclear translocation of IRF3 and phosphorylated STAT1, thereby suppressing type I interferon (IFN) signalling and IFN-mediated antiviral responses. Consequently, ectopic expression of A104R enhanced DNA virus replication and suppressed IFN production by inhibiting the IRF3-mediated type I IFN signalling pathway and suppressed the interferon-β (IFN-β)-mediated antiviral responses. Taken together, these results highlight that A104R plays a dual role in suppressing IFN response and IFN-mediated antiviral responses. This mechanism provides new insight into the A104R induced ASFV pathogenesis, which provide a critical implication for a better understanding of the ASFV pathogenesis.
- 6 November 2026
- Published by Springer Nature in Veterinary Research
- Vol. 57 (1) , 196
Open AccessAfrican swine fever virus histone-like protein A104R subverts host antiviral defenses by suppressing the nuclear translocation of IRF3 and STAT1
A104R of African swine fever virus (ASFV), putative histone-like protein, is known to be involved in essential processes such as viral DNA replication, repair, and transcription. Although it has been revealed that the deletion of A104R affects ASFV pathogenicity for live attenuated vaccine development, the molecular mechanism underlying those effects remains unclear. Here, we report a novel molecular mechanism of A104R that suppresses karyopherin-α (KPNA) mediated antiviral responses. A104R competitively bound to the major nuclear localization signal (NLS) region on KPNA3 and KPNA4, thereby disrupting their interaction with interferon regulatory factor 3 (IRF3). A104R also bound to the unique C terminal nonclassical NLS region of KPNA6 and competitively inhibited the interaction between KPNA6 and phosphorylated signal transducer and activator of transcription 1 (STAT1). Therefore, A104R inhibited the nuclear translocation of IRF3 and phosphorylated STAT1, thereby suppressing type I interferon (IFN) signalling and IFN-mediated antiviral responses. Consequently, ectopic expression of A104R enhanced DNA virus replication and suppressed IFN production by inhibiting the IRF3-mediated type I IFN signalling pathway and suppressed the interferon-β (IFN-β)-mediated antiviral responses. Taken together, these results highlight that A104R plays a dual role in suppressing IFN response and IFN-mediated antiviral responses. This mechanism provides new insight into the A104R induced ASFV pathogenesis, which provide a critical implication for a better understanding of the ASFV pathogenesis.
- Open Access
- 31 March 2026
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24 (1)
TBK1-NQO1 negative feedback loop regulates antiviral innate immunity
The online version contains supplementary material available at 10.1186/s12964-026-02850-y.
- 31 March 2026
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 24 (1)
Open AccessTBK1-NQO1 negative feedback loop regulates antiviral innate immunity
The online version contains supplementary material available at 10.1186/s12964-026-02850-y.
- Open Access
- 3 February 2026
- Published by Springer Nature in Veterinary Research
- Vol. 57 (1)
Foot-and-mouth disease virus VP4 interferes with host interferon response by targeting the nuclear translocation of interferon regulatory factor 3 (IRF3)
Upon RNA virus infection, nuclear translocation of activated transcriptional factors via the RNA-sensing signal pathway is a key event in the interferon (IFN)-mediated antiviral response, and a specific target of viral immune evasion. Foot-and-mouth disease virus (FMDV) causes an acute vesicular disease in cloven-hoofed animals and poses a serious economic risk to the dairy industry. FMDV VP4, one of the structural proteins, is an internal protein of the viral capsid and is known to play an important role in cell entry. Here, we demonstrate a novel molecular mechanism by which VP4 inhibits karyopherin (KPNA)-mediated antiviral immune responses. VP4 and IRF3 specifically interacted with the nuclear localization signal (NLS) binding site on the KPNA4 molecule, and VP4 inhibited the interaction between KPNA4 and IRF3 via competitive binding with higher affinity. Thus, VP4 inhibited nuclear translocation of IRF3 without affecting dimerization and phosphorylation of IRF3. Consequently, VP4 significantly enhanced the replication of RNA and DNA viruses by suppressing IFN production through inhibition of the IRF3-mediated type I IFN signaling pathway. Taken together, these results suggest that VP4 negatively regulates host type I IFN signaling by inhibiting the nuclear translocation of IRF3 and provide a critical implication for better understanding the pathogenesis of FMDV.
- 3 February 2026
- Published by Springer Nature in Veterinary Research
- Vol. 57 (1)
Open AccessFoot-and-mouth disease virus VP4 interferes with host interferon response by targeting the nuclear translocation of interferon regulatory factor 3 (IRF3)
Upon RNA virus infection, nuclear translocation of activated transcriptional factors via the RNA-sensing signal pathway is a key event in the interferon (IFN)-mediated antiviral response, and a specific target of viral immune evasion. Foot-and-mouth disease virus (FMDV) causes an acute vesicular disease in cloven-hoofed animals and poses a serious economic risk to the dairy industry. FMDV VP4, one of the structural proteins, is an internal protein of the viral capsid and is known to play an important role in cell entry. Here, we demonstrate a novel molecular mechanism by which VP4 inhibits karyopherin (KPNA)-mediated antiviral immune responses. VP4 and IRF3 specifically interacted with the nuclear localization signal (NLS) binding site on the KPNA4 molecule, and VP4 inhibited the interaction between KPNA4 and IRF3 via competitive binding with higher affinity. Thus, VP4 inhibited nuclear translocation of IRF3 without affecting dimerization and phosphorylation of IRF3. Consequently, VP4 significantly enhanced the replication of RNA and DNA viruses by suppressing IFN production through inhibition of the IRF3-mediated type I IFN signaling pathway. Taken together, these results suggest that VP4 negatively regulates host type I IFN signaling by inhibiting the nuclear translocation of IRF3 and provide a critical implication for better understanding the pathogenesis of FMDV.
- Open Access
- 7 January 2026
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1) , 2608395
Evaluation of the vaccine candidate ASFV-MEC-01: safety, efficacy, transmission dynamics, and assessment of reversion to virulence
African swine fever (ASF) is a highly contagious and often fatal disease that poses a serious threat to global pig farming and food security. Despite decades of research, a safe and effective vaccine has not yet been widely implemented. In our previous study, we introduced ASFV-MEC-01, a novel live attenuated vaccine candidate developed through serial passaging of a field isolate in CA-CAS-01-A cells and subsequently characterized. In the present study, we further evaluated the safety parameters of ASFV-MEC-01. Specifically, we reaffirmed the safety and protective efficacy of ASFV-MEC-01 against a highly virulent Vietnamese ASFV strain. Notably, safety assessments were also conducted in pregnant sows. Furthermore, ASFV-MEC-01 showed no evidence of horizontal transmission to sentinel pigs and did not revert to virulence after consecutive in vivo passages, confirming its phenotypic stability. The vaccine also induced a sustained immune response in vaccinated pigs. Collectively, these findings demonstrate that ASFV-MEC-01 is a promising and safe live attenuated vaccine candidate, offering a valuable tool for effective ASF control.
- 7 January 2026
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1) , 2608395
Open AccessEvaluation of the vaccine candidate ASFV-MEC-01: safety, efficacy, transmission dynamics, and assessment of reversion to virulence
African swine fever (ASF) is a highly contagious and often fatal disease that poses a serious threat to global pig farming and food security. Despite decades of research, a safe and effective vaccine has not yet been widely implemented. In our previous study, we introduced ASFV-MEC-01, a novel live attenuated vaccine candidate developed through serial passaging of a field isolate in CA-CAS-01-A cells and subsequently characterized. In the present study, we further evaluated the safety parameters of ASFV-MEC-01. Specifically, we reaffirmed the safety and protective efficacy of ASFV-MEC-01 against a highly virulent Vietnamese ASFV strain. Notably, safety assessments were also conducted in pregnant sows. Furthermore, ASFV-MEC-01 showed no evidence of horizontal transmission to sentinel pigs and did not revert to virulence after consecutive in vivo passages, confirming its phenotypic stability. The vaccine also induced a sustained immune response in vaccinated pigs. Collectively, these findings demonstrate that ASFV-MEC-01 is a promising and safe live attenuated vaccine candidate, offering a valuable tool for effective ASF control.
- Open Access
- 26 November 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 425
African swine fever virus L11L interferes with antiviral responses by targeting the IRF3 and PKR
The African Swine Fever Virus (ASFV) is a large, complex DNA virus that infects wild boars and domestic pigs. It causes African Swine Fever (ASF), an intense and often fatal disease with 100% fatality rate. After infection, ASFV employs specific viral proteins to enhance pathogenicity. However, the functions of many of these proteins remain unknown. This study investigated the molecular mechanism by which ASFV L11L evades type I interferon (IFN) pathway and protein kinase R (PKR)-mediated antiviral responses. Interestingly, we found that L11L interacts with interferon regulatory factor 3 (IRF3), specifically with the S396 and S398 amino acids, leading to the inhibition of the phosphorylation of IRF3 by Tank-binding kinase 1 (TBK1). Consequently, this interaction impedes IRF3 dimerization, nuclear translocation and subsequent IFN-β production. Besides, L11L inhibits the dimerization of PKR by targeting its K196 amino acid, preventing the phosphorylation of its substrate, eukaryotic initiation factor-2 (eIF2), to promote viral replication. Altogether, these novel findings conclude that L11L suppresses antiviral immunity and promotes viral replication, implying the identification of a novel target for the advancement of live-attenuated vaccines against ASF.
- 26 November 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 425
Open AccessAfrican swine fever virus L11L interferes with antiviral responses by targeting the IRF3 and PKR
The African Swine Fever Virus (ASFV) is a large, complex DNA virus that infects wild boars and domestic pigs. It causes African Swine Fever (ASF), an intense and often fatal disease with 100% fatality rate. After infection, ASFV employs specific viral proteins to enhance pathogenicity. However, the functions of many of these proteins remain unknown. This study investigated the molecular mechanism by which ASFV L11L evades type I interferon (IFN) pathway and protein kinase R (PKR)-mediated antiviral responses. Interestingly, we found that L11L interacts with interferon regulatory factor 3 (IRF3), specifically with the S396 and S398 amino acids, leading to the inhibition of the phosphorylation of IRF3 by Tank-binding kinase 1 (TBK1). Consequently, this interaction impedes IRF3 dimerization, nuclear translocation and subsequent IFN-β production. Besides, L11L inhibits the dimerization of PKR by targeting its K196 amino acid, preventing the phosphorylation of its substrate, eukaryotic initiation factor-2 (eIF2), to promote viral replication. Altogether, these novel findings conclude that L11L suppresses antiviral immunity and promotes viral replication, implying the identification of a novel target for the advancement of live-attenuated vaccines against ASF.
- Open Access
- 15 July 2025
- Published by Springer Nature in Chinese Medicine
- Vol. 20 (1) , 1-17
Aster tataricus extract and its active compounds display a broad spectrum of antiviral activity in vitro and in vivo
Background: Aster tataricus, a perennial terrestrial herb with a rich history of use in traditional medicine, is renowned for its therapeutic properties. However, despite the widespread use of Aster tataricus, its antiviral efficacy and mode of action against viruses have not yet been studied. Here, we demonstrated that Aster tataricus extract (ATE) has antiviral effects and an underlying mechanism of action both in vitro and in vivo. Methods: Antiviral effect of ATE was assessed against Influenza A virus (PR8), Newcastle Disease Virus (NDV), and Herpes Simplex Virus-1 (HSV) in RAW264.7 cells. Mechanism was explored by analyzing the induction of antiviral immune responses, including type-I interferon (IFN) signaling and cytokine secretion. In vivo, BALB/c mice were treated with ATE prior to infection with lethal influenza A subtypes, A/PR/8/34 (H1N1), A/Aquatic bird/Korea/W81/2005 (H5N2), and A/Chicken/Korea/116/2004 (H9N2). Survival rates, viral titers, and lung pathology were measured. High-performance liquid chromatography (HPLC) was used to identify active compounds in ATE, and their antiviral effects were further investigated. Results: An effective dose of ATE significantly inhibited influenza A virus (PR8), NDV, and HSV replication in RAW264.7 cells. Mechanistically, we found that ATE induced an antiviral state, which includes upregulation of type-I interferon signaling and secretion of IFNs and pro-inflammatory cytokines in RAW264.7 cells. In vivo, ATE treatment showed increased survival due to reduced viral titers and less severe pathological changes in the lung, and the observed prophylactic effects were associated with increased secretion of IL-6, IFN-γ, and IFN-β in bronchoalveolar lavage fluid. Based on the reported information and HPLC analysis, quercetin, kaempferol, and ferulic acid were identified as active compounds in the aqueous fraction, and an effective dose of each compound exhibited antiviral effects similar to ATE against influenza viruses. Conclusions: These findings suggest that ATE and its active compounds act as immunomodulators and may be potential candidates as a source of promising natural antivirals for animals and humans.
- 15 July 2025
- Published by Springer Nature in Chinese Medicine
- Vol. 20 (1) , 1-17
Open AccessAster tataricus extract and its active compounds display a broad spectrum of antiviral activity in vitro and in vivo
Background: Aster tataricus, a perennial terrestrial herb with a rich history of use in traditional medicine, is renowned for its therapeutic properties. However, despite the widespread use of Aster tataricus, its antiviral efficacy and mode of action against viruses have not yet been studied. Here, we demonstrated that Aster tataricus extract (ATE) has antiviral effects and an underlying mechanism of action both in vitro and in vivo. Methods: Antiviral effect of ATE was assessed against Influenza A virus (PR8), Newcastle Disease Virus (NDV), and Herpes Simplex Virus-1 (HSV) in RAW264.7 cells. Mechanism was explored by analyzing the induction of antiviral immune responses, including type-I interferon (IFN) signaling and cytokine secretion. In vivo, BALB/c mice were treated with ATE prior to infection with lethal influenza A subtypes, A/PR/8/34 (H1N1), A/Aquatic bird/Korea/W81/2005 (H5N2), and A/Chicken/Korea/116/2004 (H9N2). Survival rates, viral titers, and lung pathology were measured. High-performance liquid chromatography (HPLC) was used to identify active compounds in ATE, and their antiviral effects were further investigated. Results: An effective dose of ATE significantly inhibited influenza A virus (PR8), NDV, and HSV replication in RAW264.7 cells. Mechanistically, we found that ATE induced an antiviral state, which includes upregulation of type-I interferon signaling and secretion of IFNs and pro-inflammatory cytokines in RAW264.7 cells. In vivo, ATE treatment showed increased survival due to reduced viral titers and less severe pathological changes in the lung, and the observed prophylactic effects were associated with increased secretion of IL-6, IFN-γ, and IFN-β in bronchoalveolar lavage fluid. Based on the reported information and HPLC analysis, quercetin, kaempferol, and ferulic acid were identified as active compounds in the aqueous fraction, and an effective dose of each compound exhibited antiviral effects similar to ATE against influenza viruses. Conclusions: These findings suggest that ATE and its active compounds act as immunomodulators and may be potential candidates as a source of promising natural antivirals for animals and humans.
- Open Access
- 31 May 2025
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-20
The E3 ubiquitin ligase MARCH2 controls TNF-α mediated inflammation by autoubiquitination
Regulation of the nuclear factor-kappa B (NF-kB) signaling pathway is a major host homeostatic mechanism for controlling hyper-inflammation or chronic inflammation. Despite extensive research, the regulatory factors of NF-kB signaling required to preserve homeostasis and control inflammatory disorders are not fully understood. Moreover, the role of MARCH2 in chronic inflammation models and the regulation of MARCH2 activation remain to be elucidated. We monitored disease severity and mortality in MARCH2−/− or MARCH2+/+ mice induced experimental colitis. Susceptibility to DSS-induced experimental colitis was determined by various methods, including Swiss roll assay and fluorescein isothiocyanate (FITC)-dextran treatment, respectively. RNA-sequencing was conducted to recognize the inflammatory response-related genes in the distal colon of colitis-induced mice. Enzyme-linked immunosorbent assay (ELISA) was used to measure the cytokines and chemokines with in vitro and in vivo samples. Affinity purification and LC-MS/MS analysis were used to identify the MARCH2 interacting proteins and posttranslational modifications. The underlying mechanism was elucidated using immunoblotting, co-immunoprecipitation, ubiquitination assay, and confocal microscopy. Here, we report that MARCH2−/− mice were more susceptible to experimental inflammatory bowel disease (IBD) due to the massive production of cytokines. Stimulation by inflammatory cytokines such as TNF induces dimerization of MARCH2 at a later stage and dimerized MARCH2 undergoes K63-linked autoubiquitination at lysine 127 and 238, which promotes NEMO recognition, ubiquitination and proteasomal degradation. We also show an interaction between MARCH2 and MARCH8 in resting cells that inhibits MARCH2 activation. Taken together, these findings provide new insights into the molecular mechanism of MARCH2 and suggest a crucial role of MARCH2 in the modulation of inflammation and cellular homeostasis. Our results indicate that MARCH2 plays a critical role in regulating NEMO/IKKγ under the inflammatory and resting conditions, thereby suppressing excessive or unexpected inflammatory responses. Our findings here not only demonstrate a biological role of MARCH2 in inflammatory signaling pathways but also provide a novel insight in the underlying mechanism.
- 31 May 2025
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-20
Open AccessThe E3 ubiquitin ligase MARCH2 controls TNF-α mediated inflammation by autoubiquitination
Regulation of the nuclear factor-kappa B (NF-kB) signaling pathway is a major host homeostatic mechanism for controlling hyper-inflammation or chronic inflammation. Despite extensive research, the regulatory factors of NF-kB signaling required to preserve homeostasis and control inflammatory disorders are not fully understood. Moreover, the role of MARCH2 in chronic inflammation models and the regulation of MARCH2 activation remain to be elucidated. We monitored disease severity and mortality in MARCH2−/− or MARCH2+/+ mice induced experimental colitis. Susceptibility to DSS-induced experimental colitis was determined by various methods, including Swiss roll assay and fluorescein isothiocyanate (FITC)-dextran treatment, respectively. RNA-sequencing was conducted to recognize the inflammatory response-related genes in the distal colon of colitis-induced mice. Enzyme-linked immunosorbent assay (ELISA) was used to measure the cytokines and chemokines with in vitro and in vivo samples. Affinity purification and LC-MS/MS analysis were used to identify the MARCH2 interacting proteins and posttranslational modifications. The underlying mechanism was elucidated using immunoblotting, co-immunoprecipitation, ubiquitination assay, and confocal microscopy. Here, we report that MARCH2−/− mice were more susceptible to experimental inflammatory bowel disease (IBD) due to the massive production of cytokines. Stimulation by inflammatory cytokines such as TNF induces dimerization of MARCH2 at a later stage and dimerized MARCH2 undergoes K63-linked autoubiquitination at lysine 127 and 238, which promotes NEMO recognition, ubiquitination and proteasomal degradation. We also show an interaction between MARCH2 and MARCH8 in resting cells that inhibits MARCH2 activation. Taken together, these findings provide new insights into the molecular mechanism of MARCH2 and suggest a crucial role of MARCH2 in the modulation of inflammation and cellular homeostasis. Our results indicate that MARCH2 plays a critical role in regulating NEMO/IKKγ under the inflammatory and resting conditions, thereby suppressing excessive or unexpected inflammatory responses. Our findings here not only demonstrate a biological role of MARCH2 in inflammatory signaling pathways but also provide a novel insight in the underlying mechanism.
- Open Access
- 4 February 2025
- Published by Springer Nature in Veterinary Research
- Vol. 56 (1) , 1-16
Inhibition of STING-mediated type I IFN signaling by African swine fever virus DP71L
African swine fever virus (ASFV) is nucleocytoplasmic large DNA arbovirus and encodes many proteins involved in the interaction with host molecules to evade antiviral immune responses. Especially, evasion strategies of type I interferon (IFN-I)-mediated immune responses are crucial for early ASFV replication. However, there is still a lack of information regarding the immune evasion mechanism of ASFV proteins. Here, we demonstrated that ASFV DP71L suppresses STING-mediated antiviral responses. The conserved phosphatase 1 (PP1) motif of DP71L specifically interact with the C-terminal tail (CTT) of STING and in particular, amino acids P371, L374, and R375 of STING were important for interaction with DP71L. Consequently, this interaction disrupted the binding between STING and TANK-binding kinase 1 (TBK1), thereby inhibiting downstream signaling including phosphorylation of TBK1, STING and IRF3 for antiviral signaling. DP71L significantly interfered with viral DNA induced interferon production and IFN-mediated downstream signaling in vitro. Consistently, knockdown of DP71L enhanced antiviral gene expression in ASFV-infected cells. Taken together, these results highlight the important role of DP71L with respect to inhibition of interferon responses and provide guidance for a better understanding of ASFV pathogenesis and the development of live attenuated ASFV vaccines.
- 4 February 2025
- Published by Springer Nature in Veterinary Research
- Vol. 56 (1) , 1-16
Open AccessInhibition of STING-mediated type I IFN signaling by African swine fever virus DP71L
African swine fever virus (ASFV) is nucleocytoplasmic large DNA arbovirus and encodes many proteins involved in the interaction with host molecules to evade antiviral immune responses. Especially, evasion strategies of type I interferon (IFN-I)-mediated immune responses are crucial for early ASFV replication. However, there is still a lack of information regarding the immune evasion mechanism of ASFV proteins. Here, we demonstrated that ASFV DP71L suppresses STING-mediated antiviral responses. The conserved phosphatase 1 (PP1) motif of DP71L specifically interact with the C-terminal tail (CTT) of STING and in particular, amino acids P371, L374, and R375 of STING were important for interaction with DP71L. Consequently, this interaction disrupted the binding between STING and TANK-binding kinase 1 (TBK1), thereby inhibiting downstream signaling including phosphorylation of TBK1, STING and IRF3 for antiviral signaling. DP71L significantly interfered with viral DNA induced interferon production and IFN-mediated downstream signaling in vitro. Consistently, knockdown of DP71L enhanced antiviral gene expression in ASFV-infected cells. Taken together, these results highlight the important role of DP71L with respect to inhibition of interferon responses and provide guidance for a better understanding of ASFV pathogenesis and the development of live attenuated ASFV vaccines.
- Open Access
- 14 March 2024
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (3) , e29523
SIAH1 modulates antiviral immune responses by targeting deubiquitinase USP19
Tight control of the type I interferon (IFN) signaling pathway is critical for maintaining host innate immune responses, and the ubiquitination and deubiquitination of signaling molecules are essential for signal transduction. Deubiquitinase ubiquitin‐specific protein 19 (USP19) is known to be involved in deubiquitinating Beclin1, TRAF3, and TRIF for downregulation of the type I IFN signaling. Here, we show that SIAH1, a cellular E3 ubiquitin ligase that is involved in multicellular pathway, is a potent positive regulator of virus‐mediated type I IFN signaling that maintains homeostasis within the antiviral immune response by targeting USP19. In the early stages of virus infection, stabilized SIAH1 directly interacts with the USP19 and simultaneously mediates K27‐linked ubiquitination of 489, 490, and 610 residues of USP19 for proteasomal degradation. Additionally, we found that USP19 specifically interacts with MAVS and deubiquitinates K63‐linked ubiquitinated MAVS for negative regulation of type I IFN signaling. Ultimately, we identified that SIAH1‐mediated degradation of USP19 reversed USP19‐mediated deubiquitination of MAVS, Beclin1, TRAF3, and TRIF, resulting in the activation of antiviral immune responses. Taken together, these findings provide new insights into the molecular mechanism of USP19 and SIAH1, and suggest a critical role of SIAH1 in antiviral immune response and homeostasis.
- 14 March 2024
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (3) , e29523
Open AccessSIAH1 modulates antiviral immune responses by targeting deubiquitinase USP19
Tight control of the type I interferon (IFN) signaling pathway is critical for maintaining host innate immune responses, and the ubiquitination and deubiquitination of signaling molecules are essential for signal transduction. Deubiquitinase ubiquitin‐specific protein 19 (USP19) is known to be involved in deubiquitinating Beclin1, TRAF3, and TRIF for downregulation of the type I IFN signaling. Here, we show that SIAH1, a cellular E3 ubiquitin ligase that is involved in multicellular pathway, is a potent positive regulator of virus‐mediated type I IFN signaling that maintains homeostasis within the antiviral immune response by targeting USP19. In the early stages of virus infection, stabilized SIAH1 directly interacts with the USP19 and simultaneously mediates K27‐linked ubiquitination of 489, 490, and 610 residues of USP19 for proteasomal degradation. Additionally, we found that USP19 specifically interacts with MAVS and deubiquitinates K63‐linked ubiquitinated MAVS for negative regulation of type I IFN signaling. Ultimately, we identified that SIAH1‐mediated degradation of USP19 reversed USP19‐mediated deubiquitination of MAVS, Beclin1, TRAF3, and TRIF, resulting in the activation of antiviral immune responses. Taken together, these findings provide new insights into the molecular mechanism of USP19 and SIAH1, and suggest a critical role of SIAH1 in antiviral immune response and homeostasis.
- Open Access
- 8 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2099
The African Swine Fever Virus Virulence Determinant DP96R Suppresses Type I IFN Production Targeting IRF3
DP96R of African swine fever virus (ASFV), also known as uridine kinase (UK), encodes a virulence-associated protein. Previous studies have examined DP96R along with other genes in an effort to create live attenuated vaccines. While experiments in pigs have explored the impact of DP96R on the pathogenicity of ASFV, the precise molecular mechanism underlying this phenomenon remains unknown. Here, we describe a novel molecular mechanism by which DP96R suppresses interferon regulator factor-3 (IRF3)-mediated antiviral immune responses. DP96R interacts with a crucial karyopherin (KPNA) binding site within IRF3, disrupting the KPNA-IRF3 interaction and consequently impeding the translocation of IRF3 to the nucleus. Under this mechanistic basis, the ectopic expression of DP96R enhances the replication of DNA and RNA viruses by inhibiting the production of IFNs, whereas DP96R knock-down resulted in higher IFNs and IFN-stimulated gene (ISG) transcription during ASFV infection. Collectively, these findings underscore the pivotal role of DP96R in inhibiting IFN responses and increase our understanding of the relationship between DP96R and the virulence of ASFV.
- 8 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2099
Open AccessThe African Swine Fever Virus Virulence Determinant DP96R Suppresses Type I IFN Production Targeting IRF3
DP96R of African swine fever virus (ASFV), also known as uridine kinase (UK), encodes a virulence-associated protein. Previous studies have examined DP96R along with other genes in an effort to create live attenuated vaccines. While experiments in pigs have explored the impact of DP96R on the pathogenicity of ASFV, the precise molecular mechanism underlying this phenomenon remains unknown. Here, we describe a novel molecular mechanism by which DP96R suppresses interferon regulator factor-3 (IRF3)-mediated antiviral immune responses. DP96R interacts with a crucial karyopherin (KPNA) binding site within IRF3, disrupting the KPNA-IRF3 interaction and consequently impeding the translocation of IRF3 to the nucleus. Under this mechanistic basis, the ectopic expression of DP96R enhances the replication of DNA and RNA viruses by inhibiting the production of IFNs, whereas DP96R knock-down resulted in higher IFNs and IFN-stimulated gene (ISG) transcription during ASFV infection. Collectively, these findings underscore the pivotal role of DP96R in inhibiting IFN responses and increase our understanding of the relationship between DP96R and the virulence of ASFV.